Fivephusion Is A Globally Focusedadvanced Clinical Stagebiotech Company Driven To Optimize Cancer Therapy To Improve Patient Treatment Outcomes And Quality Of Lifethroughout Our Liveseach Of Us Will Either Experience The Trauma Of Cancer First Handor Through The Experiences Of A Family Member Or Friendunfortunatelystandard Chemotherapy Used To Treat Cancer Often Has Limited Therapeutic Benefitwith A Significant Side Effect Burden And Serious Impact On Quality Of Life We Are Developing Deflexifola C As A Replacement Of Sub Optimal Standard Of Care Therapy For The Treatment Of Metastatic Colorectal Cancerand Other Tumors With A Projected Global Incidence Of Greater Than 6 Million Patientsdeflexifola C Is Also Being Developed As A New Therapy For Cancers With High Unmet Medical Needsuch As Pediatric Ependymomaa Rare And Deadly Brain Cancer Which Afflicts Very Young Children
No conferences found for this company.
| Company Name | Fivephusion Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
